GAYNOR RICHARD Insider Trading
Get the latest insider transactions of GAYNOR RICHARD. GAYNOR RICHARD is Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in Alkermes plc. ($ALKS) and President of R&D in Neon Therapeutics, Inc. ($NTGN). Discover the current value of GAYNOR RICHARD shares.
Address: C/O NEON THERAPEUTICS, INC. 40 ERIE STREET, SUITE 110 CAMBRIDGE 02139MA
GAYNOR RICHARD is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| NTGN | Neon Therapeutics, Inc. | President of R&D | 0 | |
| ALKS | Alkermes plc. | Director | 0 | 0.00 |
| INFI | INFINITY PHARMACEUTICALS, INC. | Director | 0 | 0.00 |
Insider Trading Transactions of GAYNOR RICHARD
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Dec 04 2020 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | 18.82 | 11,509 | 216,599 | 11,509 |
| Dec 04 2020 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | 0.00 | 5,578 | 0 | 5,578 |
| May 22 2020 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | 16.85 | 12,823 | 216,068 | 12,823 |
| May 22 2020 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | 0.00 | 6,104 | 0 | 6,104 |
| May 06 2020 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Sell | 0.00 | 210,410 | 0 | 0 |
| May 06 2020 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Option Exercise | 10.20 | 58,005 | 591,651 | 0 |
| May 06 2020 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Option Exercise | 6.13 | 105,000 | 643,650 | 0 |
| May 06 2020 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Option Exercise | 2.65 | 155,373 | 411,738 | 0 |
| Mar 17 2020 | INFI | INFINITY PHARMACEUTICALS, ... | GAYNOR RICHARD | Director | Option Exercise | 0.69 | 60,000 | 41,100 | 60,000 |
| Mar 02 2020 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Sell | 1.50 | 5,625 | 8,438 | 210,410 |
| Feb 27 2020 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Sell | 1.51 | 5,465 | 8,252 | 216,035 |
| Jan 13 2020 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Buy | 0.00 | 65,000 | 0 | 221,500 |
| Dec 09 2019 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | 21.23 | 11,200 | 237,776 | 11,200 |
| Dec 09 2019 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | 21.23 | 61,800 | 1,312,014 | 61,800 |
| Nov 27 2019 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Sell | 1.37 | 20,000 | 27,498 | 201,822 |
| Nov 27 2019 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Sell | 1.31 | 23,000 | 30,231 | 178,822 |
| Nov 27 2019 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Sell | 1.24 | 22,322 | 27,644 | 156,500 |
| Nov 25 2019 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Buy | 0.00 | 75,000 | 0 | 221,822 |
| Mar 01 2019 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Buy | 0.00 | 57,500 | 0 | 146,822 |
| Mar 01 2019 | NTGN | Neon Therapeutics, Inc. | GAYNOR RICHARD | President of R&D | Option Exercise | 6.13 | 105,000 | 643,650 | 105,000 |